This inventor holds 1 USPTO granted patent. Top assignee: The State University of New York. Active years: 2010.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2010
Title: The Innovative Contributions of Abbas M. Walji
Introduction: Abbas M. Walji, an accomplished inventor based in Pasadena, California, is known for his significant contributions to the field of medicinal chemistry. With a single patent to his name, he has made strides in the development of useful compounds that serve as intermediates in the preparation of bioactive natural products.
Latest Patents: Walji's notable patent, titled "Erogorgiaene congeners and methods and intermediates useful in the preparation of same," reveals compounds that can potentially impact the pharmaceutical industry. The compounds disclosed exhibit a specific formula involving various groups such as alkyl, aryl, alkoxy, hydroxy, amino groups, and halogen atoms. These innovations enable the synthesis of erogorgiaene congeners, which include valuable natural products like pseudopterosin A and helioporin E.
Career Highlights: Walji is affiliated with the Research Foundation of the State University of New York, a leading institution in advancing scientific research and innovation. His work is integral to the foundation's mission to foster groundbreaking studies and developments in various scientific domains.
Collaborations: Throughout his career, Walji has collaborated with distinguished scientists, including Huw M. L Davies. This partnership reflects his commitment to teamwork and the pursuit of shared scientific goals, further enhancing the impact of his research.
Conclusion: Abbas M. Walji stands out as a remarkable inventor whose work in synthesizing erogorgiaene congeners contributes to the development of important bioactive compounds. His innovations not only enrich the field of medicinal chemistry but also hold the potential for further advancements in drug development and therapeutic applications.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
